Greenline Partners, LLC Haemonetics Corp Transaction History
Greenline Partners, LLC
- $675 Million
- Q1 2025
A detailed history of Greenline Partners, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Greenline Partners, LLC holds 3 shares of HAE stock, worth $202. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3Holding current value
$202% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HAE
# of Institutions
352Shares Held
53.3MCall Options Held
417KPut Options Held
314K-
Black Rock Inc. New York, NY5.96MShares$403 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$345 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.35MShares$294 Million0.24% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$177 Million0.03% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.2MShares$148 Million0.09% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.47B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...